AVORO CAPITAL ADVISORS LLC Holdings
AVORO CAPITAL ADVISORS LLC is an investment fund managing more than 5.41B US dollars. The largest holdings include Apellis Pharmaceuticals, United Therapeutics and argenx SE. In Q3 2022 the fund bought assets of total value of 390.62M US dollars and sold assets of total value of 62.97M US dollars.
AVORO CAPITAL ADVISORS LLC portfolio value:
$5.41B
portfolio value
AVORO CAPITAL ADVISORS LLC quarter portfolio value change:
+5.65%
quarter
AVORO CAPITAL ADVISORS LLC 1 year portfolio value change:
-14.51%
1 year
AVORO CAPITAL ADVISORS LLC 3 years portfolio value change:
+104.15%
3 years
AVORO CAPITAL ADVISORS LLC 5 years portfolio value change:
+204.88%
5 years
AVORO CAPITAL ADVISORS LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | 80402000 | 61891000 |
| Q2 2016 | 174635000 | 19136000 |
| Q3 2016 | 120030000 | 43995000 |
| Q4 2016 | 61676000 | 122777000 |
| Q1 2017 | 304465000 | 93099000 |
| Q2 2017 | 187013000 | 175189000 |
| Q3 2017 | 519324000 | 82748000 |
| Q4 2017 | 448999000 | 88855000 |
| Q1 2018 | 624977000 | 54275000 |
| Q2 2018 | 906105000 | 258869000 |
| Q3 2018 | 130784000 | 476157000 |
| Q4 2018 | 46272000 | 312139000 |
| Q2 2019 | 589499000 | 163411000 |
| Q3 2019 | -62828000 | 249690000 |
| Q4 2019 | 1051210000 | 89132000 |
| Q1 2020 | 171000000 | 307395000 |
| Q2 2020 | 1957408000 | 68922000 |
| Q3 2020 | 1042060000 | 329818000 |
| Q4 2020 | 1458711000 | 301936000 |
| Q1 2021 | 414323000 | 452402000 |
| Q2 2021 | 562811000 | 564548000 |
| Q3 2021 | 858023000 | 290681000 |
| Q4 2021 | 711300000 | 367978000 |
| Q1 2022 | 213761000 | 442788000 |
| Q2 2022 | 127694000 | 490538000 |
| Q3 2022 | 390615000 | 62972000 |
AVORO CAPITAL ADVISORS LLC 13F holdings
| Stock |
|---|
| Portfolio share: 12.78% Portfolio value: 691.53M Avg. open price: $50.56 Current price: $49.41 P/L: -2.29% Bought +3.26% shares Q3 2022 |
| Portfolio share: 11.32% Portfolio value: 612.75M Avg. open price: $157.99 Current price: $273.72 P/L: +73.25% Sold -1.46% shares Q3 2022 |
| Portfolio share: 8.25% Portfolio value: 446.80M Avg. open price: $131.54 Current price: $393.21 P/L: +198.93% Bought +0.84% shares Q2 2022 |
| Portfolio share: 7.16% Portfolio value: 387.65M Avg. open price: $50.48 Current price: $92.75 P/L: +83.75% Bought +4.24% shares Q2 2022 |
| Portfolio share: 6.48% Portfolio value: 350.96M Avg. open price: $86.92 Current price: $122.96 P/L: +41.46% Sold -6.34% shares Q3 2022 |
| Portfolio share: 5.86% Portfolio value: 317.18M Avg. open price: $44.05 Current price: $98.48 P/L: +123.56% Bought +2.50% shares Q3 2022 |
| Portfolio share: 5.57% Portfolio value: 301.40M Avg. open price: $85.35 Current price: $103.53 P/L: +21.30% Bought +8.27% shares Q3 2022 |
| Portfolio share: 5.44% Portfolio value: 294.29M Avg. open price: $58.76 Current price: $119.41 P/L: +103.23% Bought +25.27% shares Q3 2022 |
| Portfolio share: 5.17% Portfolio value: 279.79M Avg. open price: $11.85 Current price: $12.37 P/L: +4.36% Bought +30.73% shares Q2 2022 |
| Portfolio share: 4.71% Portfolio value: 255.18M Avg. open price: $124.5 Current price: $121.22 P/L: -2.63% Bought +22.30% shares Q3 2022 |
| Portfolio share: 4.09% Portfolio value: 221.17M Avg. open price: $177.96 Current price: $226.4 P/L: +27.22% Sold -18.75% shares Q3 2022 |
| Portfolio share: 3.27% Portfolio value: 176.89M Avg. open price: $13.17 Current price: $38.83 P/L: +194.85% Sold -1.71% shares Q2 2022 |
| Portfolio share: 2.11% Portfolio value: 114.03M Avg. open price: $13.66 Current price: $11.58 P/L: -15.22% Bought +39.23% shares Q3 2022 |
| Portfolio share: 1.96% Portfolio value: 105.84M Avg. open price: $7.65 Current price: $21.89 P/L: +186.09% Sold -17.13% shares Q3 2022 |
| Portfolio share: 1.84% Portfolio value: 99.76M Avg. open price: $113.5 Current price: $72.87 P/L: -35.80% Bought +7.72% shares Q2 2022 |
| Portfolio share: 1.64% Portfolio value: 88.86M Avg. open price: $68.94 Current price: $75.78 P/L: +9.92% Bought +18.60% shares Q3 2022 |
| Portfolio share: 1.60% Portfolio value: 86.41M Avg. open price: $17.4 Current price: $8.03 P/L: -53.86% Sold -2.17% shares Q3 2022 |
| Portfolio share: 0.99% Portfolio value: 53.4M Avg. open price: $21.64 Current price: $25.44 P/L: +17.57% Bought +0.08% shares Q2 2022 |
| Portfolio share: 0.94% Portfolio value: 51.03M Avg. open price: $9.54 Current price: $7.05 P/L: -26.07% Bought +11.03% shares Q2 2022 |
| Portfolio share: 0.89% Portfolio value: 48.15M Avg. open price: $22.08 Current price: $15.82 P/L: -28.37% Sold -26.56% shares Q3 2022 |
| Portfolio share: 0.87% Portfolio value: 47.22M Avg. open price: $34.43 Current price: $29.11 P/L: -15.45% Bought +72.16% shares Q3 2022 |
| Portfolio share: 0.74% Portfolio value: 40.26M Avg. open price: $12.32 Current price: $13.42 P/L: +8.89% Bought +55.76% shares Q3 2022 |
| Portfolio share: 0.69% Portfolio value: 37.15M Avg. open price: $19.82 Current price: $13.67 P/L: -31.03% Bought +35.82% shares Q1 2022 |
| Portfolio share: 0.67% Portfolio value: 36.41M Avg. open price: $28.34 Current price: $9.89 P/L: -65.10% Sold -1.29% shares Q3 2022 |
| Portfolio share: 0.67% Portfolio value: 36.05M Avg. open price: $5.92 Current price: $4.17 P/L: -29.59% Bought +96.19% shares Q3 2020 |
| Portfolio share: 0.57% Portfolio value: 31.05M Avg. open price: $72.62 Current price: $39.83 P/L: -45.15% Bought +226.09% shares Q2 2022 |
| Portfolio share: 0.52% Portfolio value: 28.11M Avg. open price: $3.39 Current price: $4.61 P/L: +36.02% Bought +3.41% shares Q2 2022 |
| Portfolio share: 0.51% Portfolio value: 27.47M Avg. open price: $9.68 Current price: $9.43 P/L: -2.57% Bought +1.56% shares Q3 2022 |
| Portfolio share: 0.44% Portfolio value: 23.67M Avg. open price: $22.96 Current price: $11.18 P/L: -51.30% Bought +11.54% shares Q3 2022 |
| Portfolio share: 0.40% Portfolio value: 21.80M Avg. open price: $25.16 Current price: $34.51 P/L: +37.16% Bought +91.11% shares Q1 2022 |
| Portfolio share: 0.39% Portfolio value: 20.94M Avg. open price: $8.14 Current price: $4.63 P/L: -43.13% Sold -2.63% shares Q1 2022 |
| Portfolio share: 0.38% Portfolio value: 20.40M Avg. open price: N/A Current price: $34.16 P/L: N/A Sold -4.82% shares Q1 2022 |
| Portfolio share: 0.34% Portfolio value: 18.29M Avg. open price: N/A Current price: $38.55 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.18% Portfolio value: 9.72M Avg. open price: $9.55 Current price: $9.57 P/L: +0.17% Sold -28.14% shares Q4 2021 |
| Portfolio share: 0.17% Portfolio value: 8.94M Avg. open price: N/A Current price: $18.36 P/L: N/A N/A Q2 2022 |
| Portfolio share: 0.12% Portfolio value: 6.54M Avg. open price: $11.2 Current price: $1.18 P/L: -89.51% Bought +200.00% shares Q3 2020 |
| Portfolio share: 0.10% Portfolio value: 5.61M Avg. open price: N/A Current price: $7.69 P/L: N/A N/A Q3 2021 |
| Portfolio share: 0.10% Portfolio value: 5.57M Avg. open price: N/A Current price: $2.81 P/L: N/A N/A Q4 2021 |
| Portfolio share: 0.08% Portfolio value: 4.42M Avg. open price: N/A Current price: $10.52 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $104.62 Current price: $82.88 P/L: -20.78% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.11 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.01 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 42 AVORO CAPITAL ADVISORS's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of AVORO CAPITAL ADVISORS LLC?
The biggest position of the AVORO CAPITAL ADVISORS LLC is Apellis Pharmaceuticals, Inc. (APLS) with 12.78% portfolio share worth of 691.54M US dollars.
Top 5 AVORO CAPITAL ADVISORS's holdings represent 46% of the portfolio:
- Apellis Pharmaceuticals, Inc. (APLS) – 12.78%
- United Therapeutics Corporation (UTHR) – 11.32%
- argenx SE (ARGX) – 8.25%
- Mirati Therapeutics, Inc. (MRTX) – 7.16%
- Sarepta Therapeutics, Inc. (SRPT) – 6.48%
Who is the portfolio manager of AVORO CAPITAL ADVISORS LLC?
The portfolio manager of the AVORO CAPITAL ADVISORS LLC is .
What is the total asset value of the AVORO CAPITAL ADVISORS LLC portfolio?
AVORO CAPITAL ADVISORS LLC total asset value (portfolio value) is 5.41B US dollars.
Who is ?
is the portfolio manager of the AVORO CAPITAL ADVISORS LLC.
What is (AVORO CAPITAL ADVISORS LLC) fund performance?
AVORO CAPITAL ADVISORS's quarterly performance is +5.65%, annualy -14.51%. In the past 3 years, the value of 's portfolio has increased by +104%. In the past 5 years, the value of the portfolio has increased by +205%.
What is the AVORO CAPITAL ADVISORS LLC CIK?
AVORO CAPITAL ADVISORS's Central Index Key is 0001633313 .